Results 71 to 80 of about 569,058 (302)

Enhancing digital road networks for better transportation in developing countries

open access: yesTransportation Research Interdisciplinary Perspectives
Data scarcity in developing countries often poses significant challenges to the use of analytics in addressing development issues. In transportation research, digitized road data is one of the most fundamental data structures, and a poorly digitized road
V.F. Stienen   +3 more
doaj   +1 more source

International Assistance and Cooperation for Access to Essential Medicines [PDF]

open access: yes, 2010
Access to essential medicines is a critical problem that plagues many developing countries. With a daunting number of domestic constraints technologically, economically, and otherwise developing countries are faced with a steep uphill battle to meet the ...
Mok, Emily A.
core   +1 more source

Access to medicines for acute illness in middle income countries in Central America [PDF]

open access: yes, 2013
OBJECTIVE To analyze the main predictors of access to medicines for persons who experienced acute health conditions. METHODS This was a cross-sectional analytic study, based on data from household surveys.
Camacho, Luiz Antonio Bastos   +3 more
core   +4 more sources

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

Changes in essential cancer medicines and association with cancer outcomes: an observational study of 158 countries

open access: yesBMC Cancer
Background Cancer is a major cause of mortality worldwide, and differences in cancer mortality rates between countries are, in part, due to differences in access to cancer care, including medicines.
Moizza Zia Ul Haq   +5 more
doaj   +1 more source

Judicial litigations and social welfare: access to medicines in two towns in the Santa Catarina State, Brazil - 10.4025/actascihealthsci.v34ispec.10084

open access: yesActa Scientiarum. Health Sciences, 2012
The growing number of lawsuits to obtain free medicines from the Brazilian Health System (SUS) is analyzed to characterize the supply of the requested drugs in two towns with different social and economic characteristics and different municipal ...
Silvana Nair Leite   +2 more
doaj   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Prescription for the People: An Activist\u27s Guide to Making Medicine Affordable for All [PDF]

open access: yes, 2017
[Excerpt] Because every cure starts with an accurate diagnosis, in this book I explain how and why the current medicines system is dysfunctional and corrupt.
Quigley, Fran
core   +1 more source

Emergency supply of prescription-only medicines to patients by community pharmacists: a mixed methods evaluation incorporating patient, pharmacist and GP perspectives [PDF]

open access: yes, 2015
Objective To evaluate and inform emergency supply of prescription-only medicines by community pharmacists (CPs), including how the service could form an integral component of established healthcare provision to maximise adherence. Design Mixed methods.
Ashcroft, Darren M   +7 more
core   +2 more sources

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy